Could GLP-1 drugs help breast cancer patients live longer?

[News]

A large retrospective cohort study of adult female breast cancer patients found that GLP-1 receptor agonist use was associated with better all-cause survival and recurrence-free survival in patients with obesity or type 2 diabetes. The strongest associations were seen versus non-use in obesity and versus insulin or metformin in type 2 diabetes, while comparisons with SGLT2 inhibitors were less consistent and require further study.

More... (https://www.news-medical.net/news/20260512/Could-GLP-1-drugs-help-breast-cancer-patients-live-longer.aspx)